Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.62M.
ENTERPRISE VALUE (EV)
$2.62M
Allarity Therapeutics, Inc.
Market Cap
$15.91M
Enterprise Value (EV)
$2.62M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | $15.91M | $2.62M |
| BioCardia, Inc. (BCDA)vs › | $16.22M | $12.40M |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | $14.48M |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | $20.16M |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | $19.56M |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | $4.44M |
| IN8bio, Inc. (INAB)vs › | $13.62M | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | $5.68M |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | $18.63M |
Market Cap
$15.91M
Total Debt
$1.40M
Cash
$14.69M
Enterprise Value
$2.62M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
